ERBB2 and cancer: Within the homo- and heterotypic MDA-MB-231 model, a minor, low-differentiated subpopulation of CD24−CD44+ cancer stem cells was found to be enriched compared to the luminal subtype MCF7 and the HER2+ SK-BR3 subtype.